In particular, the Aβ42 to Aβ40 ratio is decreased early in the progression of AD and is inversely correlated with plaque formation found on Amyloid-PET3,12, while phosphorylated tau protein levels are increased in AD patients and reflect disease severity13,14. This evidence concerns the gene MAPT and Alzheimer disease.